Bone Health in Adrenal Disorders

Area of Science:

• Endocrinology
• Bone Metabolism
• Nephrology

Background:

• Secondary osteoporosis is a significant health concern, potentially reversible with proper diagnosis and treatment.
• Hyperfunctional adrenal masses, including Cushing's syndrome, pheochromocytoma, and primary aldosteronism, are linked to high morbidity and mortality, primarily cardiovascular risk.
• Emerging evidence suggests adrenal hormones may directly impair bone metabolism.

Purpose of the Study:

• To review the role of adrenal disorders as secondary causes of osteoporosis.
• To highlight pheochromocytoma and primary aldosteronism as key conditions to investigate.
• To emphasize the importance of addressing secondary causes to prevent fractures and overtreatment.

Main Methods:

• Literature review of experimental and clinical studies.
• Analysis of the impact of adrenal hormones on bone metabolism.
• Focus on pheochromocytoma and primary aldosteronism in the context of osteoporosis.

Main Results:

• Adrenal disorders can lead to secondary osteoporosis.
• Pheochromocytoma and primary aldosteronism are implicated in bone fragility.
• Adrenal hormones may exert direct negative effects on bone health.

Conclusions:

• Adrenal disorders are critical secondary causes of osteoporosis that require attention.
• Diagnosing and treating pheochromocytoma and primary aldosteronism can potentially reverse osteoporosis.
• Targeting secondary causes improves fracture risk management and avoids unnecessary anti-osteoporotic drug use.